Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark W Hull

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Journal of Clinical Pharmacology|January 31, 2009
Lopinavir/ritonavir pharmacokinetics in a substitution of high-dose soft-gelatin capsule to tablet formulationMark W Hull, Marianne Harris, Viviane Lima, et al.
AIDS Research and Therapy|November 4, 2017
HIV treatment simplification to elvitegravir/cobicistat/emtricitabine/tenofovir disproxil fumarate (E/C/F/TDF) plus darunavir: a pharmacokinetic studyMarianne Harris, Bruce Ganase, Birgit Watson, et al.
American Journal of Infection Control|May 21, 2017
Antimicrobial stewardship for hospitalized patients with viral respiratory tract infectionsChristopher F Lowe, Michael Payne, David Puddicombe, et al.
HIV Clinical Trials|January 10, 2017
Efficacy and safety of "unboosting" atazanavir in a randomized controlled trial among HIV-infected patients receiving tenofovir DFMarianne Harris, Bruce Ganase, Birgit Watson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 12, 2008
Large community outbreak of Streptococcus pneumoniae serotype 5 invasive infection in an impoverished, urban populationMarc G Romney, Mark W Hull, Réka Gustafson, et al.
The International Journal on Drug Policy|March 29, 2017
Knowledge of hepatitis C and treatment willingness amongst people who inject drugs in an era of direct acting antiviralsAllison Mah, Mark W Hull, Kora DeBeck, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|October 7, 2014
HIV and liver transplantation: The British Columbia experience, 2004 to 2013Clara Tan-Tam, Pamela Liao, Julio S Montaner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 31, 2012
Factors associated with discordance between absolute CD4 cell count and CD4 cell percentage in patients coinfected with HIV and hepatitis C virusMark W Hull, Kathleen Rollet, Adefowope Odueyungbo, et al.
Sexually Transmitted Diseases|June 10, 2021
Interest in Hypothetical Preexposure Prophylaxis Against Herpes Simplex Virus: A Cross-Sectional SurveyDarrell H S Tan, Farideh Tavangar, Laura Fusca, et al.
Journal of the International AIDS Society|May 9, 2014
Comparing the efficacy of efavirenz and boosted lopinavir using viremia copy-yearsViviane D Lima, Juan Sierra-Madero, Zunyou Wu, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Journal of Clinical Pharmacology|January 31, 2009
Lopinavir/ritonavir pharmacokinetics in a substitution of high-dose soft-gelatin capsule to tablet formulationMark W Hull, Marianne Harris, Viviane Lima, et al.
AIDS Research and Therapy|November 4, 2017
HIV treatment simplification to elvitegravir/cobicistat/emtricitabine/tenofovir disproxil fumarate (E/C/F/TDF) plus darunavir: a pharmacokinetic studyMarianne Harris, Bruce Ganase, Birgit Watson, et al.
American Journal of Infection Control|May 21, 2017
Antimicrobial stewardship for hospitalized patients with viral respiratory tract infectionsChristopher F Lowe, Michael Payne, David Puddicombe, et al.
HIV Clinical Trials|January 10, 2017
Efficacy and safety of "unboosting" atazanavir in a randomized controlled trial among HIV-infected patients receiving tenofovir DFMarianne Harris, Bruce Ganase, Birgit Watson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 12, 2008
Large community outbreak of Streptococcus pneumoniae serotype 5 invasive infection in an impoverished, urban populationMarc G Romney, Mark W Hull, Réka Gustafson, et al.
The International Journal on Drug Policy|March 29, 2017
Knowledge of hepatitis C and treatment willingness amongst people who inject drugs in an era of direct acting antiviralsAllison Mah, Mark W Hull, Kora DeBeck, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|October 7, 2014
HIV and liver transplantation: The British Columbia experience, 2004 to 2013Clara Tan-Tam, Pamela Liao, Julio S Montaner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 31, 2012
Factors associated with discordance between absolute CD4 cell count and CD4 cell percentage in patients coinfected with HIV and hepatitis C virusMark W Hull, Kathleen Rollet, Adefowope Odueyungbo, et al.
Sexually Transmitted Diseases|June 10, 2021
Interest in Hypothetical Preexposure Prophylaxis Against Herpes Simplex Virus: A Cross-Sectional SurveyDarrell H S Tan, Farideh Tavangar, Laura Fusca, et al.
Journal of the International AIDS Society|May 9, 2014
Comparing the efficacy of efavirenz and boosted lopinavir using viremia copy-yearsViviane D Lima, Juan Sierra-Madero, Zunyou Wu, et al.
Pageof 6